蓝晓科技(300487):Q3单季度毛利率历史新高,加速布局生命科学业务

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [6]. Core Insights - The company achieved a record high single-quarter gross margin of 55.6% in Q3 2025, driven by an increase in high-margin businesses such as life sciences and metal resources [2][4]. - For the first three quarters of 2025, the company reported a revenue of 1.933 billion yuan, a year-on-year increase of 2.2%, and a net profit attributable to the parent company of 652 million yuan, up 9.3% year-on-year [1][2]. - The third quarter of 2025 saw a revenue of 686 million yuan, marking a 14.9% year-on-year increase and a 2.3% quarter-on-quarter increase [1][2]. Financial Performance - The gross margin for the first three quarters of 2025 was 52.81%, with the third quarter achieving a gross margin of 55.6%, the highest since the company's listing [2]. - The net profit margin for Q3 2025 was 30.42%, showing a decline due to increased expense ratios and higher income tax [3]. - The company plans to invest in a high-end materials industrial park for life sciences, purchasing 270 acres of land in Pucheng High-tech Zone [4]. Future Outlook - The company has set profit forecasts for 2025-2027 at 1.011 billion yuan, 1.322 billion yuan, and 1.596 billion yuan respectively, indicating a positive growth trajectory [4]. - The establishment of a subsidiary in Sweden aims to strengthen the company's presence in the European life sciences market [4].